glp-1 news insurers Perspectives from employers on the costs and issues associated with covering agonists for weight loss Cigna drops coverage of GLP-1

News on the molecular regulation and function of hepatic low-density lipoprotein receptor and LDLR-related protein 1

For adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) CALQUENCE Dosage FIXED-DURATION TREATMENT FOR PREVIOUSLY UNTREATED CLL/SLL Treatment cycles (each cycle is 28 days, or 4 weeks) CONTINUOUS TREATMENT FOR PREVIOUSLY UNTREATED AND PREVIOUSLY TREATED CLL/SLL *Take each tablet by mouth

Semaglutide GLP-1 also improves glycemic control, though its effect may be slightly less pronounced

doi:10.1371/journal.pone.0035240

Ipamorelin has a favorable safety profile, and many users take it for extended periods (6+ months) under medical supervision